Danya Allen, PA
Medical · Northglenn, CONPI 1174953244
Payments from drug & device makers
Across 286 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$600
- Boehringer Ingelheim$578
- Novo Nordisk$464
- Lilly USA, LLC$431
- Amgen$324
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,440100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $1,147 |
| AstraZeneca | 36 | $600 |
| Boehringer Ingelheim | 32 | $578 |
| Novo Nordisk | 23 | $464 |
| Lilly USA, LLC | 24 | $431 |
| Amgen | 15 | $324 |
| GSK | 12 | $250 |
| Bayer | 11 | $188 |
| Sanofi-aventis U.S. LLC | 5 | $107 |
| Astellas Pharma US Inc | 4 | $104 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Abbott | 5 | $101 |
| Merck | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 5 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $91 |
| Exact Sciences | 3 | $76 |
| Pfizer | 4 | $75 |
| Corium, LLC | 2 | $59 |
| Nestle Healthcare Nutrition Inc. | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Idorsia Pharmaceuticals US Inc | 4 | $52 |
| Edwards Lifesciences | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Boston Scientific | 2 | $33 |
| Aimmune Therapeutics, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Medtronic | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Nevro Corp. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $13 |
How this compares
$5,440 in reported general payments places this provider in the 85th percentile of 766 medical providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 21 | $22,366 |
| OzempicSemaglutide | 13 | $12,905 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $10,664 |
| Rosuvastatin Calcium | 42 | $961 |
| Olmesartan Medoxomil | 14 | $617 |
| Fluticasone Propionate | 12 | $569 |
| Atorvastatin Calcium | 32 | $475 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $408 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $339 |
| Levothyroxine Sodium | 28 | $245 |
| Amlodipine Besylate | 22 | $157 |
| Lisinopril | 28 | $150 |
| Cephalexin | 12 | $94 |
| Prednisone | 16 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $431 | $22,36621 claims |
| Novo NordiskOzempic | $464 | $12,90513 claims |
| AstraZenecaBreztri Aerosphere | $600 | $10,66414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 766 medical providers in Colorado.
Other medical in Northglenn
- Christen KutzColorado Springs$2.4M
- Amanda MixonFort Collins$342K
- Kristin RyggColorado Springs$255K
- Jordan MastDenver$247K
- John NovakAurora$173K
- Michelle BarnettColorado Springs$138K
- Michael JacobsonFort Collins$131K
- Lindsey TunstallAurora$87K
- Jennifer NafzigerHighlands Ranch$80K
- Daniel TaylorDenver$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.